Home › Scleroderma › Pennsylvania
Scleroderma clinical trials in Pennsylvania
10 studies for Scleroderma are looking for participants at sites in Pennsylvania.
Cities in Pennsylvania
A Study to Assess the Efficacy and Safety of Efgartigimod PH20 SC in Adults With Systemic Sclerosis
- Perelman Center for Advanced Medicine, Philadelphia
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Sep 24, 2026 · NCT06655155Testing an Immunotherapy Anti-cancer Drug, Nivolumab, for Advanced Cancers in Patients With Autoimmune Disorders, AIM-NIVO
- UPMC Hillman Cancer Center, Pittsburgh
RecruitingPhase 1
Ages 18 and older · All sexes · Updated Sep 23, 2026 · NCT03816345A Study to Test Whether Nerandomilast Helps People With Systemic Sclerosis
- University of Pennsylvania, Philadelphia
- Thomas Jefferson University, Philadelphia
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Sep 17, 2026 · NCT07497087A Study of the Efficacy and Safety of Belimumab in Adults With Systemic Sclerosis Associated Interstitial Lung Disease
- GSK Investigational Site, Philadelphia
- GSK Investigational Site, Philadelphia
- GSK Investigational Site, Pittsburgh
RecruitingPhase 2/3
Ages 18 and older · All sexes · Updated Sep 8, 2026 · NCT05878717Platform Clinical Study for Conquering Scleroderma
- University of Pennsylvania, Philadelphia
- Thomas Jefferson University Hospital, Philadelphia
RecruitingPhase 2
Ages 18 and older · All sexes · Updated Aug 18, 2026 · NCT06195072Autologous Stem Cell Transplantation in Patients With Systemic Sclerosis
- Children's Hospital of Pittsburgh of UPMC, Pittsburgh
- University of Pittsburgh Medical Center, Pittsburgh
- University of Pittsburgh Medical Center, Pittsburgh
RecruitingPhase 2
Ages 8 to 60 · All sexes · Updated Aug 14, 2026 · NCT03630211A Phase 1 Study of FT819 in B-cell Mediated Autoimmune Disease
- Jefferson Einstein Hospital Philadelphia, Philadelphia
RecruitingPhase 1
Ages 12 to 70 · All sexes · Updated May 22, 2026 · NCT06308978Intralesional Injection of STS in Treatment of Calcinosis
- UPMC Arthritis and Autoimmunity Center, Pittsburgh
RecruitingPhase 2
Ages 18 and older · All sexes · Updated May 5, 2026 · NCT06672822The Apollo Device in Systemic Sclerosis for the Management of fatiguE, Raynaud Phenomenon and qualiTy of Life
- University of Pittsburgh and UPMC Scleroderma Center, Pittsburgh
Recruiting
Ages 18 and older · All sexes · Updated Jan 8, 2026 · NCT06675344Autologous Stem Cell Transplant (ASCT) for Autoimmune Diseases
- Children's Hospital of Philadelphia, Philadelphia
RecruitingPhase 2
Ages 8 to 25 · All sexes · Updated Oct 14, 2025 · NCT05029336From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.